Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Dec;16(6):869–872. doi: 10.1128/aac.16.6.869

Effect of cefamandole nafate on blood coagulation and platelet function.

G M Custer, B R Briggs, R E Smith
PMCID: PMC352969  PMID: 533268

Abstract

Platelet function and coagulation were tested after brief in vivo exposure to cefamandole nafate and in the presence of various concentrations of the drug in vitro. Alterations in hemostatic function were observed only with exposure to drug concentrations severalfold higher than those expected to prevail clinically.

Full text

PDF
869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRECHER G., CRONKITE E. P. Morphology and enumeration of human blood platelets. J Appl Physiol. 1950 Dec;3(6):365–377. doi: 10.1152/jappl.1950.3.6.365. [DOI] [PubMed] [Google Scholar]
  2. BUCKELL M. The effect of citrate on euglobulin methods of estimating fibrinolytic activity. J Clin Pathol. 1958 Sep;11(5):403–405. doi: 10.1136/jcp.11.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown C. H., 3rd, Natelson E. A., Bradshaw W., Williams T. W., Jr, Alfrey C. P., Jr The hemostatic defect produced by carbenicillin. N Engl J Med. 1974 Aug 8;291(6):265–270. doi: 10.1056/NEJM197408082910601. [DOI] [PubMed] [Google Scholar]
  4. Griffith R. S., Black H. R., Brier G. L., Wolny J. D. Cefamandole: in vitro and clinical pharmacokinetics. Antimicrob Agents Chemother. 1976 Nov;10(5):814–823. doi: 10.1128/aac.10.5.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Grose W. E., Bodey G. P., Stewart D. Observations in man on some pharmacologic features of cefamandole. Clin Pharmacol Ther. 1976 Nov;20(5):579–584. doi: 10.1002/cpt1976205579. [DOI] [PubMed] [Google Scholar]
  6. Hardisty R. M., Hutton R. A. Platelet aggregation and the availability of platelet factor 3. Br J Haematol. 1966 Nov;12(6):764–776. doi: 10.1111/j.1365-2141.1966.tb00164.x. [DOI] [PubMed] [Google Scholar]
  7. JIM R. T. A study of the plasma thrombin time. J Lab Clin Med. 1957 Jul;50(1):45–60. [PubMed] [Google Scholar]
  8. Johnsson H., Niklasson P. M. Effects of some antibiotics of platelet function in vitro and in vivo. Thromb Res. 1977 Aug;11(2):237–251. doi: 10.1016/0049-3848(77)90042-1. [DOI] [PubMed] [Google Scholar]
  9. Lerner P. I., Lubin A. Letter: Coagulopathy with cefazolin in uremia. N Engl J Med. 1974 Jun 6;290(23):1324–1324. doi: 10.1056/NEJM197406062902317. [DOI] [PubMed] [Google Scholar]
  10. MUSTARD J. F., HEGARDT B., ROWSELL H. C., MACMILLAN R. L. EFFECT OF ADENOSINE NUCLEOTIDES ON PLATELET AGGREGATION AND CLOTTING TIME. J Lab Clin Med. 1964 Oct;64:548–559. [PubMed] [Google Scholar]
  11. Mielke C. H., Jr, Kaneshiro M. M., Maher I. A., Weiner J. M., Rapaport S. I. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood. 1969 Aug;34(2):204–215. [PubMed] [Google Scholar]
  12. Natelson E. A., Brown C. H., 3rd, Bradshaw M. W., Alfrey C. P., Jr, Williams T. W., Jr Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob Agents Chemother. 1976 Jan;9(1):91–93. doi: 10.1128/aac.9.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. PROCTOR R. R., RAPAPORT S. I. The partial thromboplastin time with kaolin. A simple screening test for first stage plasma clotting factor deficiencies. Am J Clin Pathol. 1961 Sep;36:212–219. doi: 10.1093/ajcp/36.3.212. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES